Bioceres Crop Solutions Corporation is a developer of seed, crop protection and crop nutrition technologies aimed at helping its grower customers achieve carbon neutrality. Its products include germplasm, seeds and seed treatments, as well as inoculants, herbicides, insecticides, fungicides and biofertilizers. Headquartered in Argentina, it serves customers from facilities in Uruguay, France and South Africa. The Company claims first mover status in drought tolerant, wheat and soy crops and claims over 200 patents and applications for its technologies.
Bioceres Crop Solutions, in our view, is likely to report financial results in the next few quarters that offered positive year-over-year comparisons. Investor sentiment toward nearly all sectors except technology has been tempered due to the halting recovery from the coronavirus pandemic. We believe valuation metrics have become so high traders have been forced to look back toward manufacturing, industry and agriculture. Like many in these sectors, Bioceres has proven remarkably resourceful in dealing with the pandemic policies that have led to business shutdown and travel restrictions. Its success is being made evident with each reported quarter.
The Company has introduced a new wheat seed trait and germplasm product for the 2022 growing season. Given the success of the same technology platform for soy bean, we expect strong uptake by grower customers. This provides yet another catalyst for Biocere’s sales and earnings.
Please register and subscribe to view more details in a 14-page report dated February 8, 2021.